Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Journals » Journal of Pain Management » Volume 10 Issue 1 Articles » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Doxycycline: Medical Uses and Effects
$82.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Deactivating implantable cardioverter-defibrillators (ICDs) in cancer patients: A scoping review of ethical considerations (pp. 99-105)
Tell A Friend
 
Tell someone you know about this product.
Deactivating implantable cardioverter-defibrillators (ICDs) in cancer patients: A scoping review of ethical considerations (pp. 99-105) $45.00
Authors:  Adrianne Lebner Maxwell J. Smith
Abstract:
Implantable cardioverter-defibrillators (ICDs) were developed in the 1980s to treat patients with life-threatening arrhythmias. These surgically implanted devices have since improved survival in patients, meaning that patients with ICDs are now surviving long enough to develop other fatal illnesses, like cancer. With patients surviving longer and developing terminal illnesses, it is important for health care practitioners to discuss the deactivation of ICDs as part of advance care planning discussions, as ICDs may not necessarily align with patientsí goals of care at the end of life. However, while important, this practice is not without ethical controversy. This scoping review therefore aims to explore the key ethical considerations and challenges that have been discussed in the literature regarding the deactivation of ICDs in terminally ill patients, and focuses specifically on patients with cancer. A search strategy of 3 electronic databases (Embase, Cochrane, and MEDLINE) was employed to identify relevant literature. Central themes identified in this literature that explores or examines ethical considerations for the deactivation of ICDs in cancer patients include: Conceptualizing ICDs as Medical Devices versus Biological Transplants; Autonomy, Informed Consent, and Advance Directives; Deactivating ICDs versus Euthanasia; and ICDs versus Pacemakers and Left Ventricular Assist Devices. There is broad agreement in the literature regarding the ethical permissibility of deactivating ICDs in patients with terminal illnesses such as cancer; however, this review indicates that ethical uncertainty and challenges will likely persist due to reported physician discomfort regarding the deactivation of ICDs and the absence of discussions regarding the deactivation of ICDs in advance care planning conversations. 


Available Options:
Version:
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2019

Deactivating implantable cardioverter-defibrillators (ICDs) in cancer patients: A scoping review of ethical considerations (pp. 99-105)